Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Metabolon
Entity

Metabolon

Tracked across 2 events · 14 articles · First seen Feb 17, 2026 · Last active Mar 18, 2026

Sentiment
70
Attention
4
Events
2
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (2)
4 70
Tech
Metabolon's Platform Reveals CAR T-cell Neurotoxicity Pathways
Metabolon's metabolomics platform was instrumental in the largest metabolomic study ever conducted in CAR T-cell therapy, revealing new insights into severe neurotoxicity. This enhances Metabolon's reputation as a leader in metabolomics solutions and could lead to increased demand for its services.
Feb 17, 2026 · 7 articles
4 70
Business
Metabolon and MJFF Collaborate on Parkinson's Biomarker Discovery
Metabolon is collaborating with The Michael J. Fox Foundation to advance multiomic analyses for Parkinson's disease research. This partnership leverages Metabolon's Global Discovery Platform to support biomarker discovery and biological pathway understanding, enhancing its position as a leader in metabolomics solutions.
Mar 17, 2026 · 7 articles
Relationships (2)
Ro Hastie CEO ↔ Metabolon Ro Hastie is the CEO of Metabolon, a global leader in metabolomics solutions.
Gilead Sciences===Kite Pharma service provider ↔ Metabolon Metabolon provided its metabolomics platform for research conducted by Gilead Sc
NEWSDESK
Track Metabolon live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.